Clinical Trial

Rhomboid Intercostal Block vs Erector Spinae Block

Study acronym: RIB-ESPB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Trial Details
NCT Number NCT07040618
Lead Sponsor Cairo University
Conditions Lung Cancer
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-17